PATENT CLAIM ANALYSIS

Application Number: 16277871
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "346000"]

Abstract:
The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.

Claim (Index 3):
The method of  claim 1 , comprising further administering to said subject riluzole, a salt thereof, or sustained-release formulation thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 99.0
- Lexical Diversity: 1.37037
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14473245', '16100923', '15005222', '14473142', '15011900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8182489421252002
- 35 USC 102 Novelty (BERT): 0.6924396103313191
- Combined Prediction Score: 0.805668008945812
- Mean Citation Score: 635.188344
- Max Citation Score: 722.7521
- Similarity Product: 694.1686283671199

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test